Common Side Effects Gastrointestinal: Nausea, vomiting, abdominal cramps, and diarrhea the most common adverse effects, occurring primarily at doses exceeding 3 g/day [1][5][7]
BPC-157 can be used in longer cycles for chronic conditions, though many clinicians structure it as defined blocks rather than indefinite use
MicroRNA-197 mediates the overgrowth and anti-apoptotic effects by downregulating insulin-like growth factor-binding protein-3 during nephroblastoma tumorigenesis
10.3390/ijms131113830 77 MatteraR.BenvenutoM.GigantiM
8 weeks: ~5 vials 12 weeks: ~8 vials 16 weeks: ~10 vials Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 8 weeks (loading daily): ~56 syringes 16 weeks (loading daily): ~112 syringes Bacteriostatic Water (10 mL bottles) Use 2.0 mL per 10 mg vial for reconstitution
Furthermore, no statistical methods were used to pre-determine sample sizes, but our sample sizes are similar to those reported in previous publications 15,16,17